THE CELLULAR NUCLEIC ACID BINDING PROTEIN REGULATES THE ALZHEIMER’S DISEASE β-SECRETASE PROTEIN BACE1
Alzheimer’s disease (AD) is the most common neurodegenerative disease affecting the elderly population and is believed to be caused by the overproduction and accumulation of the toxic amyloid beta (Aβ) peptide in the brain. Aβ is produced by two separate enzymatic cleavage events of the larger membr...
Main Author: | Holler, Christopher J |
---|---|
Format: | Others |
Published: |
UKnowledge
2012
|
Subjects: | |
Online Access: | http://uknowledge.uky.edu/biochem_etds/12 http://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1006&context=biochem_etds |
Similar Items
-
Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s disease
by: Alireza Vakilian, et al.
Published: (2019-06-01) -
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
by: Miguel A. Maia, et al.
Published: (2019-03-01) -
THE CELLULAR NUCLEIC ACID BINDING PROTEIN IN AGING AND DISEASE
by: Webb, Robin
Published: (2013) -
Electrochemical Detection of Alzheimer’s Disease Biomarker, β-Secretase Enzyme (BACE1), With One-Step Synthesized Reduced Graphene Oxide
by: Dey, J., et al.
Published: (2022) -
Glycosaminoglycans from <i>Litopenaeus vannamei</i> Inhibit the Alzheimer’s Disease β Secretase, BACE1
by: Courtney J. Mycroft-West, et al.
Published: (2021-04-01)